Prescribing and switching patterns of biologic therapy in patients with psoriasis: real-world experience
Up to 2% of the patients with psoriasis received treatment with biologics. Anti-IL-17 was the preferred first- and second-line biologic agent used in Malaysia.
Authors
- Chai Har Loo (ORCID: https://orcid.org/0000-0001-5487-8570)
- Min Tang (ORCID: https://orcid.org/0000-0002-8350-5148)
- Suganthy Robinson (ORCID: https://orcid.org/0000-0001-9987-7547)
- Suganthi Thevarajah (ORCID: https://orcid.org/0000-0001-9558-1802)
Institutions
- Hospital Kuala Lumpur (MY)
- Hospital Pulau Pinang (MY)
- Sarawak General Hospital (MY)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-11-09
- DOI
- https://doi.org/10.1093/ced/llaf496
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00